30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Edward Ludwig

Track

Insider profile

Currently holds positions in CVS Health Corp and Boston Scientific Corp

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
12 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director CVS Health Corp Nov. 1, 2018 -
Lead Independent Director Boston Scientific Corp April 15, 2016 -
Lead Independent Director Aetna Inc Feb. 24, 2012 - Nov. 28, 2018
Independent Director Xylem Inc Oct. 31, 2011 - May 9, 2017
Independent Director Boston Scientific Corp March 1, 2014 - April 15, 2016
Executive Chairman of the Board Becton Dickinson and Co Oct. 1, 2011 - July 1, 2012
Independent Director Aetna Inc June 27, 2003 - Feb. 24, 2012
Edward Ludwig's trades of Boston Scientific Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-21 2026-05-20
B Purchase
35,802 -2.6%
186.05
US$354,762 		35,802 -2.6% 186.05 US$354,762
2025-07-28 2025-07-25
S Sale
89,784 +44.3%
432.87
US$4,430,209 		89,784 +44.3% 432.87 US$4,430,209
2025-07-25 2025-07-25
PrS Proposed sale
81,094
373.52
US$1,585,295 		81,094 373.52 US$1,585,295
2025-05-30 2025-05-29
S Sale
4,000 -15.1%
104.59
US$418,368 		4,000 -15.1% 104.59 US$418,368
2025-05-29 2025-05-29
PrS Proposed sale
4,000
104.54
US$418,160 		4,000 104.54 US$418,160
2025-02-12 2025-02-11
S Sale
12,000 -33.0%
105.48
US$1,265,815 		12,000 -33.0% 105.48 US$1,265,815
2025-02-11 2025-02-11
PrS Proposed sale
12,000
105.48
US$1,265,816 		12,000 105.48 US$1,265,816
2024-11-22 2024-11-21
S Sale
4,877 -11.0%
91.63
US$446,902 		4,877 -11.0% 91.63 US$446,902
2024-11-21 2024-11-21
PrS Proposed sale
4,877
91.63
US$446,902 		4,877 91.63 US$446,902
2024-05-02 2024-05-02
B Purchase
1,000 +4.8%
53.88
US$53,879 		1,000 +4.8% 53.88 US$53,879
2024-04-29 2024-04-26
S Sale
9,818 -19.2%
73.29
US$719,562 		9,818 -19.2% 73.29 US$719,562
2024-04-26 2024-04-26
PrS Proposed sale
9,818
73.29
US$719,562 		9,818 73.29 US$719,562
2024-02-14 2024-02-13
S Sale
7,000 -14.5%
65.03
US$455,223 		7,000 -14.5% 65.03 US$455,223
2024-02-13 2024-02-13
PrS Proposed sale
7,000
65.03
US$455,223 		7,000 65.03 US$455,223
2023-11-06 2023-11-03
B Purchase
2,000 +10.7%
70.47
US$140,930 		2,000 +10.7% 70.47 US$140,930
2022-02-11 2022-02-10
B Purchase
1,000 +5.8%
105.90
US$105,904 		1,000 +5.8% 105.90 US$105,904
2021-02-17 2021-02-17
B Purchase
3,000 +26.5%
72.00
US$216,000 		3,000 +26.5% 72.00 US$216,000
2019-03-11 2019-03-08
B Purchase
2,000 +37.2%
52.80
US$105,600 		2,000 +37.2% 52.80 US$105,600
2019-03-04 2019-03-01
B Purchase
4,000 +290.3%
58.27
US$233,080 		4,000 +290.3% 58.27 US$233,080
2004-07-01 2004-07-01
PlS Planned sale
19,000 -18.1%
49.59
US$942,210 		19,000 -18.1% 49.59 US$942,210